alpha-aminopyridine has been researched along with Symptom Cluster in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Cardinali, V; Cerchione, C; Falini, B; Martelli, MP; Martinelli, G; Martino, G | 1 |
Attar, EC; de Botton, S; DiNardo, CD; Fathi, AT; Gupta, I; Kenvin, L; Kline, I; Stein, EM | 1 |
Blot, K; Falconer, C; Marschall-Kehrel, D; Michel, MC; Radziszewski, P | 1 |
Lundh, H; Nilsson, O; Rosén, I | 1 |
Lang, B; Newsom-Davis, J; Wray, DW | 1 |
1 review(s) available for alpha-aminopyridine and Symptom Cluster
Article | Year |
---|---|
Enasidenib and ivosidenib in AML.
Topics: Aminopyridines; Antineoplastic Agents; Cell Differentiation; Clinical Trials as Topic; Glutarates; Glycine; Humans; Isocitrate Dehydrogenase; Isocitrates; Ketoglutaric Acids; Leukemia, Myeloid, Acute; Multicenter Studies as Topic; Mutation, Missense; NADP; Pyridines; Syndrome; Triazines | 2020 |
2 trial(s) available for alpha-aminopyridine and Symptom Cluster
Article | Year |
---|---|
Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Syndrome; Triazines | 2018 |
Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.
Topics: Aged; Aminopyridines; Analgesics; Benzhydryl Compounds; Chemical and Drug Induced Liver Injury; Cresols; Double-Blind Method; Female; Humans; Liver; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive | 2012 |
2 other study(ies) available for alpha-aminopyridine and Symptom Cluster
Article | Year |
---|---|
Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine.
Topics: 4-Aminopyridine; Aged; Amifampridine; Aminopyridines; Autoimmune Diseases; Female; Humans; Middle Aged; Myasthenia Gravis; Pyridostigmine Bromide; Syndrome | 1984 |
The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle.
Topics: 4-Aminopyridine; Action Potentials; Aminopyridines; Animals; Calcium Channels; Heart; Heart Ventricles; Humans; Immunoglobulin G; In Vitro Techniques; Mice; Neuromuscular Diseases; Reference Values; Syndrome; Tetrodotoxin; Ventricular Function; Verapamil | 1988 |